2025
SJR Q1
JCR Q2 · 4,1
42 eşleşen makale
SCIE
Dergi ayrıntısı
Pharmaceutical Research
- Yayıncı
- Springer
- Ülke
- United States · Northern America
- Tür
- journal
- ISSN
-
072487411573904X
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,873
- Quartile Q1
- H-Index 241
- Atıf/yayın 4,02
- Doküman (3y) 625
- Atıf (3y) 2.839
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 4,1
- 5Y JIF 4,4
- JCI 0,8
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
Alanlar
WoS kategorileri
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 0,873 | 4,1 | 4,4 | 0,8 | Q2 | 241 |
| 2024 | Q1 | Q1 | 0,871 | 4,3 | 4,1 | 0,8 | Q2 | 235 |
| 2023 | Q2 | Q2 | 0,707 | 3,5 | 3,8 | 0,82 | Q2 | 235 |
| 2022 | Q2 | Q2 | 0,644 | 3,7 | 4 | 0,8 | Q2 | 235 |
| 2021 | Q2 | Q2 | 0,658 | 4,6 | 4,9 | 0,85 | Q2 | 235 |
| 2020 | Q1 | Q2 | 0,815 | 4,2 | 4,5 | 0,86 | Q2 | 235 |
| 2019 | Q1 | Q2 | 0,913 | 3,2 | 3,6 | 0,91 | Q1 | 235 |
| 2018 | — | Q1 | — | 3,9 | 3,8 | 0,98 | Q1 | — |
| 2017 | Q1 | Q2 | 1,077 | 3,3 | 3,5 | 0,97 | Q1 | 235 |
| 2016 | Q1 | Q2 | 1,112 | 3 | 3,6 | — | — | 235 |
| 2015 | Q1 | Q2 | 1,155 | 3,3 | 4 | — | — | 235 |
| 2014 | Q1 | Q1 | 1,35 | 3,4 | 4,3 | — | — | 235 |
| 2013 | Q1 | Q1 | 1,57 | 4 | 4,7 | — | — | 235 |
| 2012 | Q1 | Q1 | 1,895 | 4,7 | 5 | — | — | 235 |
| 2011 | Q1 | Q1 | 1,678 | 4,1 | 4,7 | — | — | 235 |
| 2010 | Q1 | Q1 | 1,925 | 4,5 | 4,5 | — | — | 235 |
| 2009 | — | Q1 | — | 3,9 | 3,9 | — | — | — |
| 2008 | — | Q1 | — | 4 | 3,8 | — | — | — |
| 2007 | — | Q1 | — | 2,7 | 3,4 | — | — | — |
| 2006 | — | Q1 | — | 2,8 | — | — | — | — |
| 2005 | — | Q1 | — | 2,8 | — | — | — | — |
| 2004 | — | Q1 | — | 2,3 | — | — | — | — |
| 2003 | — | Q1 | — | 2,6 | — | — | — | — |
| 2002 | — | Q1 | — | 2,4 | — | — | — | — |
| 2001 | — | Q1 | — | 2,8 | — | — | — | — |
| 2000 | — | Q1 | — | 2,5 | — | — | — | — |
| 1999 | — | Q1 | — | 2,8 | — | — | — | — |
| 1998 | — | Q1 | — | 2,5 | — | — | — | — |
| 1997 | — | Q1 | — | 2,2 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | Q2 | 100/250 |
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 106/356 |
| 2024 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | Q2 | 81/239 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q2 | 69/352 |
| 2023 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | Q2 | 90/231 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 100/354 |
| 2022 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | Q2 | 82/178 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 111/278 |
| 2021 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | Q2 | 70/179 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 90/279 |
| 2020 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | Q2 | 66/178 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 97/276 |
| 2019 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | Q1 | 71/177 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 97/271 |
| 2018 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | Q1 | 52/172 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q2 | 54/267 |
| 2017 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | Q1 | 61/171 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 74/261 |
| 2016 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 60/166 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 87/257 |
| 2015 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 51/163 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 66/255 |
| 2014 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q1 | — | 39/157 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 64/255 |
| 2013 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q1 | — | 31/148 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 39/256 |
| 2012 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q1 | — | 25/152 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 26/261 |
| 2011 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q1 | — | 30/154 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 42/261 |
| 2010 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q1 | — | 22/147 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 33/252 |
| 2009 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q1 | — | 24/140 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 40/237 |
| 2008 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q1 | — | 20/127 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 42/219 |
| 2007 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q1 | — | 27/128 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 71/205 |
| 2006 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q1 | — | 26/124 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 58/199 |
| 2005 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q1 | — | 21/125 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 54/193 |
| 2004 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q1 | — | 24/125 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 61/187 |
| 2003 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q1 | — | 21/123 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 49/185 |
| 2002 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q1 | — | 20/119 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 51/188 |
| 2001 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q1 | — | 15/118 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 32/186 |
| 2000 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q1 | — | 17/118 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 37/181 |
| 1999 | CHEMISTRY | SCIE | Q1 | — | 13/121 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 24/175 |
| 1998 | CHEMISTRY | SCIE | Q1 | — | 13/126 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 28/178 |
| 1997 | CHEMISTRY | SCIE | Q1 | — | 16/111 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 31/157 |